# Preservative-free Tafluprost Eye Drops in Newly Diagnosed Patients With Glaucoma

> **NCT04455126** · PHASE2,PHASE3 · COMPLETED · sponsor: **Alexandria University** · enrollment: 30 (actual)

## Conditions studied

- Glaucoma

## Interventions

- **DRUG:** Preservative-free tafluprost eye drops

## Key facts

- **NCT ID:** NCT04455126
- **Lead sponsor:** Alexandria University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-01
- **Primary completion:** 2018-12-30
- **Final completion:** 2020-06-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04455126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04455126, "Preservative-free Tafluprost Eye Drops in Newly Diagnosed Patients With Glaucoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04455126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*